• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脱氧胸苷激酶与慢性淋巴细胞白血病患者外周血淋巴细胞的胸苷摄取相关。

Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia.

作者信息

Källander C F, Simonsson B, Gronowitz J S, Nilsson K

出版信息

Eur J Haematol. 1987 Apr;38(4):331-7. doi: 10.1111/j.1600-0609.1987.tb00007.x.

DOI:10.1111/j.1600-0609.1987.tb00007.x
PMID:3609253
Abstract

The serum thymidine kinase (S-TK) and proliferative activity of the leukemic cells were determined in 27 untreated patients with chronic lymphocytic leukemia (CLL). A significant positive correlation between S-TK and proliferation expressed as a proliferative index (PI) was found (r = 0.70, p less than 0.001). Additionally, PI (r = 0.59, p less than 0.01) and S-TK (r = 0.47, p less than 0.05) correlated to peripheral blood lymphocyte count. When different variables and combinations of variables were studied in order to define their capacity for discriminating between progressive and indolent CLL, S-TK activity and PI proved to be powerful indications. In longitudinal studies, both S-TK and PI paralleled disease activity. A model where a combination of S-TK and PI gives information of the degree of localized disease is proposed.

摘要

对27例未经治疗的慢性淋巴细胞白血病(CLL)患者测定了血清胸苷激酶(S-TK)和白血病细胞的增殖活性。发现S-TK与以增殖指数(PI)表示的增殖之间存在显著正相关(r = 0.70,p < 0.001)。此外,PI(r = 0.59,p < 0.01)和S-TK(r = 0.47,p < 0.05)与外周血淋巴细胞计数相关。为了确定不同变量及变量组合区分进展性和惰性CLL的能力而进行研究时,S-TK活性和PI被证明是有力的指标。在纵向研究中,S-TK和PI均与疾病活动平行。提出了一个模型,其中S-TK和PI的组合可提供局部疾病程度的信息。

相似文献

1
Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia.血清脱氧胸苷激酶与慢性淋巴细胞白血病患者外周血淋巴细胞的胸苷摄取相关。
Eur J Haematol. 1987 Apr;38(4):331-7. doi: 10.1111/j.1600-0609.1987.tb00007.x.
2
Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia.血清脱氧胸苷激酶可为慢性淋巴细胞白血病提供预后信息。
Cancer. 1984 Dec 1;54(11):2450-5. doi: 10.1002/1097-0142(19841201)54:11<2450::aid-cncr2820541123>3.0.co;2-r.
3
Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.非霍奇金淋巴瘤患者血清胸苷激酶活性:与其他预后因素的关系。
Klin Wochenschr. 1988 Aug 15;66(16):718-23. doi: 10.1007/BF01726414.
4
Lymphocyte thymidine kinase and treatment response in acute lymphocytic leukemia.
Leuk Res. 1987;11(2):149-54. doi: 10.1016/0145-2126(87)90020-8.
5
Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.血清β2微球蛋白和血清胸苷激酶是慢性淋巴细胞白血病和免疫细胞瘤无进展生存期的独立预测指标。
Leuk Lymphoma. 1996 Aug;22(5-6):439-47. doi: 10.3109/10428199609054782.
6
3H-thymidine uptake in chronic lymphocytic leukaemia cells.
Scand J Haematol. 1980 Feb;24(2):169-73. doi: 10.1111/j.1600-0609.1980.tb02363.x.
7
[Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].[慢性淋巴细胞白血病中脂蛋白脂肪酶和血清胸苷激酶水平及其与其他预后因素的相关性]
Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):8-12.
8
Prognostic value of thymidine kinase activity in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者中胸苷激酶活性的预后价值
Postepy Hig Med Dosw (Online). 2016 Dec 30;70(0):1321-1330. doi: 10.5604/17322693.1227556.
9
Thymidine kinase isoenzymes in human acute and chronic lymphatic leukemia.
Leuk Res. 1986;10(6):637-42. doi: 10.1016/0145-2126(86)90266-3.
10
Thymidine kinase isoenzymes in chronic lymphocytic leukaemia.
Br J Haematol. 1981 Nov;49(3):479-81. doi: 10.1111/j.1365-2141.1981.tb07251.x.

引用本文的文献

1
Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.中国慢性淋巴细胞白血病患者血清胸苷激酶1浓度及其与其他预后因素的相关性。
Int J Hematol. 2009 Sep;90(2):205-211. doi: 10.1007/s12185-009-0380-8. Epub 2009 Jul 24.
2
Cytofluorometric determination of thymidine kinase activity in a mixture of normal and neoplastic cells.正常细胞与肿瘤细胞混合物中胸苷激酶活性的细胞荧光测定法。
Br J Cancer. 1993 May;67(5):1022-5. doi: 10.1038/bjc.1993.187.
3
Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
非霍奇金淋巴瘤患者血清胸苷激酶活性:与其他预后因素的关系。
Klin Wochenschr. 1988 Aug 15;66(16):718-23. doi: 10.1007/BF01726414.
4
Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.胸苷激酶:一种对非霍奇金淋巴瘤具有预后价值且具有广泛潜在临床应用的肿瘤标志物。
Ann Hematol. 1992 Jul;65(1):1-5. doi: 10.1007/BF01715117.